Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine vs Fludarabine in Relapsed CLL
NCT01423032Phase 3Completed
- Sponsor
- Wisp
- Start
- Sep 2001
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bendamustine in chronic lymphocytic leukemia (CLL), sponsored by Wisp. Started Sep 2001; status: completed.
02
Drugs
bendamustine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01423032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01423032.